| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |